Belančić, A., Strbad, T., Kučan Štiglić, M. & Vitezić, D. (2023). Effectiveness of Nusinersen in Type 1, 2 and 3 Spinal Muscular Atrophy: Croatian Real-World Data. Journal of Clinical Medicine, 12. (8). doi: 10.3390/jcm12082839
Belančić, Andrej, et al. "Effectiveness of Nusinersen in Type 1, 2 and 3 Spinal Muscular Atrophy: Croatian Real-World Data." Journal of Clinical Medicine, vol. 12, no. 8, 2023. https://doi.org/10.3390/jcm12082839
Belančić, Andrej, Tea Strbad, Marta Kučan Štiglić and Dinko Vitezić. "Effectiveness of Nusinersen in Type 1, 2 and 3 Spinal Muscular Atrophy: Croatian Real-World Data." Journal of Clinical Medicine 12, no. 8 (2023). https://doi.org/10.3390/jcm12082839
Belančić, A., et al. (2023) 'Effectiveness of Nusinersen in Type 1, 2 and 3 Spinal Muscular Atrophy: Croatian Real-World Data', Journal of Clinical Medicine, 12(8). doi: 10.3390/jcm12082839
Belančić A, Strbad T, Kučan Štiglić M, Vitezić D. Effectiveness of Nusinersen in Type 1, 2 and 3 Spinal Muscular Atrophy: Croatian Real-World Data. Journal of Clinical Medicine [Internet]. 2023 April 13 [cited 2024 August 21];12(8). doi: 10.3390/jcm12082839
A. Belančić, T. Strbad, M. Kučan Štiglić and D. Vitezić, "Effectiveness of Nusinersen in Type 1, 2 and 3 Spinal Muscular Atrophy: Croatian Real-World Data", Journal of Clinical Medicine, vol. 12, no. 8, April 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:375868. [Accessed: 21 August 2024]